Neurocrine Biosciences (NBIX) Tops Q4 EPS by 22c, Guides FY13 Below Street
Tweet Send to a Friend
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q4 EPS of $0.14, $0.22 better than ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
